Home > News > Protiveris Received MIPS Award for Technology Optimization
April 1st, 2004
Protiveris Received MIPS Award for Technology Optimization
Protiveris Inc., a bio- nanotechnology company commercializing bioMEMS technologies to facilitate protein research and the discovery of new pharmaceuticals, today announced that it is a recipient of a $116,000 award from the Maryland Industrial Partnerships (MIPS) program. This award is to be used for the optimization of microfluidic sample delivery system in the VeriScan(TM) 3000 -- the Company's patent pending biosensor system for advanced biological and chemical detection.
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014
Nanometrics Announces Upcoming Investor Events July 22nd, 2014
Harris & Harris Group Invests in UberSeq, Inc. July 16th, 2014
Harris & Harris Group Portfolio Company D-Wave Systems Closes a $28.4 Million Financing July 14th, 2014